
SITANOW-M 1000
MRP: 3,600
Packaging: 10x15
Pack Type: tablet
Composition:
Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg
Indication:
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Description:
Sitagliptin 50mg combined with Metformin Hydrochloride IP 1000mg is a fixed-dose oral antidiabetic medication used to manage type 2 diabetes mellitus. This combination leverages two complementary mechanisms to improve glycemic control:
Sitagliptin is a DPP-4 inhibitor that increases incretin hormone levels, enhancing insulin secretion and suppressing glucagon release in a glucose-dependent manner.
Metformin Hydrochloride is a biguanide that reduces hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake.
Together, they effectively lower fasting and postprandial blood glucose and HbA1c levels. This medication is prescribed alongside diet and lifestyle changes to optimize diabetes management.
Tags:
- Dual mechanism for improved blood glucose control
- Lowers HbA1c, fasting, and post-meal glucose
- Enhances insulin secretion and reduces glucose production
- May support weight management
- Convenient oral dosing
Usage Information
Dosage
Take one tablet twice daily or as prescribed Administer with meals to minimize gastrointestinal side effects Follow your healthcare provider’s guidance strictly
Side Effects
Gastrointestinal discomfort (nausea, diarrhea, abdominal pain) Headache Hypoglycemia (especially with other diabetes medicines) Vitamin B12 deficiency with long-term Metformin use Rare allergic reactions Seek medical help if you experience symptoms of lactic acidosis, severe allergic reactions, or persistent side effects.
Contraindications
Type 1 diabetes mellitus Diabetic ketoacidosis Severe renal impairment or metabolic acidosis Hypersensitivity to Sitagliptin, Metformin, or any excipients Acute or chronic metabolic acidosis including lactic acidosis
Availability
Sitagliptin Metformin tablets Sitagliptin 50mg + Metformin 1000mg DPP-4 inhibitor and Metformin combo Type 2 diabetes oral medication Blood sugar control tablets Diabetes combination therapy Oral hypoglycemic agents
